4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-035435
CEO bought 3,315 shares at $15.07 ($49,957)
From the SEC's structured data for this filing
Trades in this filing
Gline Matthew · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-18 | Purchase : show line 1 in the form | +3,315 | $15.07 | $49,957 | 17,287,081 | D |
| Open-market purchases · 3,315 sh · avg $15.07 · $49,957 | ||||||
Loading xslF345X05/form4.xml…